Zribi, A., Al Riyami, K., Al Zahibi, H. S., & Burney, I. A. (2024). Managing the Adverse Events Associated with Pembrolizumab and Lenvatinib Therapy in Endometrial Cancer. Sultan Qaboos University Medical Journal, 24(2), 293–297. https://doi.org/10.18295/squmj.9.2023.057